Barbara Allen

Barbara is an accomplished operations executive with over two decades of experience in the private equity space. She has enabled both private equity-backed and public companies to accelerate growth by reimagining organizational structures, optimizing operations, and modernizing technology. Barbara is widely recognized as a visionary leader who engages employees at all levels and leverages diverse perspectives to drive transformational initiatives. With a commitment to continuous improvement, she has a proven track record of establishing operational discipline and leveraging data analytics to propel businesses to success.

Barbara has successfully led several key transactions, including the sale of ChartOne’s services business to HealthPort for $98 million and the sale of M*Modal to One Equity Partners for $1.1 billion. Throughout her career, she has drawn from deep expertise in healthcare technology, business optimization, operational strategy, and business integration to maximize profitability and foster highly productive cultures, producing measurable financial and operational improvements.

Most recently, Barbara was a key member of the leadership team through the sale of Kemberton to Revecore. At Kemberton (now Revecore), Barbara served as the Chief Operating Officer, where she was brought in to restructure the organization and enable growth. She directed a team of over 350 employees and had full P&L responsibility. In this role, she leveraged data and performance insights to increase productivity by 20% and reduce turnover by 50% by introducing an employee engagement program and leading a cultural transformation.

More directly, Barbara previously served as the Executive Vice President & General Manager at CIOX Health, where she directed 5 business units with over 400 people and established formal processes across the organization. During this time, she brought significant growth and improvements to the private equity-owned business, expanding the business from $10M in 2012 to $48M in 2017 through both organic strategies and acquisitions.